title: Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system.
abstract: Multiple sclerosis is a demyelinating disorder of the central nervous system (CNS), in which an immune attack directed against myelin constituents causes myelin destruction and death of oligodendrocytes, the myelin-producing cells. Here, the efficacy of nerve growth factor (NGF), a growth factor for neurons and oligodendrocytes, in promoting myelin repair was evaluated using the demyelinating model of experimental allergic encephalomyelitis (EAE) in the common marmoset. Surprisingly, we found that NGF delayed the onset of clinical EAE and, pathologically, prevented the full development of EAE lesions. We demonstrate by immunocytochemistry that NGF exerts its antiinflammatory effect by downregulating the production of interferon gamma by T cells infiltrating the CNS, and upregulating the production of interleukin 10 by glial cells in both inflammatory lesions of EAE and normal-appearing CNS white matter. Thus, NGF, currently under investigation in human clinical trials as a neuronal trophic factor, may be an attractive candidate for therapy of autoimmune demyelinating disorders.
authors.affiliation: Department of Neurology, University of California at San Francisco, San Francisco, California 94143-0435, USA.
authors.forename: P
authors.initials: P
authors.lastname: Villoslada
authors.forename: S L
authors.initials: SL
authors.lastname: Hauser
authors.forename: I
authors.initials: I
authors.lastname: Bartke
authors.forename: J
authors.initials: J
authors.lastname: Unger
authors.forename: N
authors.initials: N
authors.lastname: Heald
authors.forename: D
authors.initials: D
authors.lastname: Rosenberg
authors.forename: S W
authors.initials: SW
authors.lastname: Cheung
authors.forename: W C
authors.initials: WC
authors.lastname: Mobley
authors.forename: S
authors.initials: S
authors.lastname: Fisher
authors.forename: C P
authors.initials: CP
authors.lastname: Genain
mesh_terms: D000818:Animals; D002144:Callithrix; D002490:Central Nervous System / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D007150:Immunohistochemistry; D007371:Interferon-gamma / Q000096:biosynthesis*; D016753:Interleukin-10 / Q000096:biosynthesis*; D020932:Nerve Growth Factor / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D018417:Th1 Cells / Q000187:drug effects / Q000276:immunology; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology
chemical_list: D011994:Recombinant Proteins; D016753:Interleukin-10; D007371:Interferon-gamma; D020932:Nerve Growth Factor